Cargando…
Clindamycin-rifampin combination therapy for staphylococcal periprosthetic joint infections: a retrospective observational study
BACKGROUND: Staphylococcal species account for more than 50% of periprosthetic joint infections (PJI) and antimicrobial therapy with rifampin-based combination regimens has been shown effective. The present study evaluates the safety and efficacy of clindamycin in combination with rifampin for the m...
Autores principales: | Leijtens, Borg, Elbers, Joris B. W., Sturm, Patrick D., Kullberg, Bart Jan, Schreurs, Berend W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5414295/ https://www.ncbi.nlm.nih.gov/pubmed/28464821 http://dx.doi.org/10.1186/s12879-017-2429-2 |
Ejemplares similares
-
Clinical Outcome of Antibiotic Suppressive Therapy in Patients with a Prosthetic Joint Infection after Hip Replacement
por: Leijtens, Borg, et al.
Publicado: (2019) -
If, When, and How to Use Rifampin in Acute Staphylococcal Periprosthetic Joint Infections, a Multicentre Observational Study
por: Beldman, Mark, et al.
Publicado: (2021) -
Correction to: If, When, and How to Use Rifampin in Acute Staphylococcal Periprosthetic Joint Infections, a Multicentre Observational Study
por: Beldman, Mark, et al.
Publicado: (2022) -
691 Rifampin in the Treatment of Staphylococcal Prosthetic Joint Infections
por: Parsaei, Shadi, et al.
Publicado: (2014) -
Delayed Rifampin Administration in the Antibiotic Treatment of Periprosthetic Joint Infections Significantly Reduces the Emergence of Rifampin Resistance
por: Darwich, Ali, et al.
Publicado: (2021)